2018 annual financial data

Theravance Biopharma 2018 Net margin

Theravance Biopharma 2018 net margin with verified reported values.

Direct answer

Net margin was -357.01%.

Operating income was -238,751,000 USD and net income was -215,524,000 USD.
Operating cash flow was -112,867,000 USD.

Get free Theravance Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
60,370,000 USD
Operating income
-238,751,000 USD
Net income
-215,524,000 USD
Operating cash flow
-112,867,000 USD